Awareness and acceptability of Human Papillomavirus (HPV) vaccine among staff of Obafemi Awolowo University, lle-lfe , Nigeria
Barre latérale de l'article
Contenu principal de l'article
Résumé
The study was carried out to document awareness, and acceptability of Human Papillomavirus virus (HPV) vaccines amongst staff of Obafemi Awolowo University lle-lfe. A cross-sectional survey of 400 members of staff who are parents of female children aged 10-19 years was conducted. Information on awareness on HPV infection and vaccine, attitude towards and parental acceptability of vaccine were collected using a structured self administered questionnaire. A total of 400 questionnaires were administered, 385(96.3%) were correctly filled and analysed. Only few (16.6 %) have heard of HPV infection, of which 31.7 % obtained information from the hospital. Majority (92%) believed that it protects against cervical cancer, 18.7% believed it causes HPV infection and 49.6% believed it will promote promiscuity. Majority ((84.4%) agreed that the vaccine should be included in the routine immunisation schedule. Most of the parents (81.0%) were willing to accept HPV vaccination. Parental
belief that the vaccine prevent cervical cancer (β=0.38, P<0.001) and parental agreement of its inclusion in routine immunisation (β= 0.12, P=0.002) were predictors of increased HPV acceptability. Increased parental HPV acceptability was associated with the belief that HPV vaccination was beneficial and protective to health. There is a need for it to be included in the pre-school immunisation programme.
Keywords: Parental acceptability, HPV vaccine, Awareness
Summary
The study was carried out to document awareness, and acceptability of Human Papillomavirus virus (HPV) vaccines amongst staff of Obafemi Awolowo University lle-lfe. A cross-sectional survey of 400 members of staff who are parents of female children aged 10-19 years was conducted. Information on awareness on HPV infection and vaccine, attitude towards and parental acceptability of vaccine were collected using a structured self administered questionnaire. A total of 400 questionnaires were administered, 385(96.3%) were correctly filled and analysed. Only few (16.6 %) have heard of HPV infection, of which 31.7 % obtained information from the hospital. Majority (92%) believed that it protects against cervical cancer, 18.7% believed it causes HPV infection and 49.6% believed it will promote promiscuity. Majority ((84.4%) agreed that the vaccine should be included in the routine immunisation schedule. Most of the parents (81.0%) were willing to accept HPV vaccination. Parental belief that the vaccine prevent cervical cancer (β=0.38, P<0.001) and parental agreement of its inclusion in routine immunisation (β= 0.12, P=0.002) were predictors of increased HPV acceptability. Increased parental HPV acceptability was associated with the belief that HPV vaccination was beneficial and protective to health. There is a need for it to be included in the pre-school immunisation programme.
Correspondence: Dr. O.A. Esimai, Department of Community Medicine, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria. E-mail: pejuesimai@yahoo.com
Details de l'article
Rubrique
Références
Ho GY, Bierman R, Beardsley L, Chang CJ and Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998, 338(7):423-428.
Kotloff KL, Wasserman SS, Russ K, Shapiro S, Daniel R, Brown W, Frost A, Tabara SO and Shah K: Detection of genital human papillomavirus and associated cytological abnormalities among college women. Sex Transm Dis 1998, 25(5):243-250.
Franco E and Harper DM: Vaccination against human papillomavirus infection: A new paradigm in cervical cancer control. Vaccine 2005, 23(17–18):2388-2394.
Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE and Fortenberry JD: A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005, 191(2):182-192.
Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Desy M and Rohan TE: Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high risk area for cervical cancer. J Infect Dis 1999, 180(5):1415-1423.
Bosch, F. X., and Muñoz, N. The viral etiology of cervical cancer. Virus Research, 2002, 89: 183-190.
Giordano G, D’Adda T, Gnetti L, Froio E, Merisio C and Melpignano M: Detection of human papillomavirus in organs of upper genital tract in women with cervical cancer. Int J Gynecol Cancer 2006, 16(4):1601-1607
Schiffman M and Castle PE: Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 2003, 127(8):930-934.
Davis D, Dickman E D, Ferris D, and Dias, J. K. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. Journal of Lower Genital Tract Disease, 2004, 8: 188-194.
Koutsky L ., Ault, K A, Wheeler C M, Brown D R Barr, E, Alvarez, F B et al. Controlled trial of human papillomavirus type 16 vaccine.N Engl J Med.2002,347: 1645-1651.
Villa, L. L., Costa, R. L. R., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R. et al. Prophylatic quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicenter phase II efficacy trial. Lancet Oncology.2005, 6: 271-278.
Herrero R, Castle PE, Schiffman M, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis. 2005;191: 1796 –1807
Stone KM, Karem KL, Sternberg MR, et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis. 2002;186 :1396 –1402
Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis. 2001;183 :1554 –1564
Mays RM, Sturm LA and Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med. 2004;58 :1405 –1413
Freeman VA and Freed GL. Parental knowledge, attitudes, and demand regarding a vaccine to prevent varicella. Am J Prev Med. 1999;17 :153 –155
Poland GA and Jacobson RM. Understanding those who do not understand: a brief review of the anti-vaccine movement. Vaccine. 2001;19: 2440 –2445
Rosenthal SL, Kottenhahn RK, Biro FM and Succop PA. Hepatitis B vaccine acceptance among adolescents and their parents. J Adolesc Health. 1995;17 :248 –254
Zimet GD, Fortenberry JD, Fife KH, Tyring SK, Herne K and Douglas JM. Acceptability of genital herpes immunization. The role of health beliefs and health behaviors. Sex Transm Dis. 1997;24 :555 –560
John M, Yelena B, David D. B, Sasha C. K, Matthew B and Enrique S-Toriello. A Pilot Study: HPV Infection Knowledge and HPV Vaccine Acceptance among Women Residing in Ciudad Juárez, México. Californian Journal of Health Promotion 2006, (4); 3, 177-186.
Obiechina, N J A (NJ); Diwe, K (K) and Ikpeze, O C (OC); Knowledge, awareness and perception of sexually transmitted diseases (STDs) among Nigerian adolescent girls. J Obstet Gynaecol; 2002, 22: 302-305.
Constantine NA and Jerman P: Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health 2007, 40(2):108-115.
Waller J, Marlow LA and Wardle J: Mothers’ attitudes towards preventing cervical cancer through humanpapillomavirus vaccination:a qualitative study. Cancer Epidemiol Biomarkers Prev 2006, 15(7):1257-1261.
Dempsey AF, Zimet GD, Davis RL and Koutsky L: Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 2006, 117(5):1486-1493.
Lazcano-Ponce E, Rivera L, Arillo-Santillan E, Salmeron J, Hernandez- Avila M and Munoz N: Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res 2001, 32(3):243-247.
Zimet GD, Mays RM, Winston Y, Kee R, Dickes J and Su L: Acceptability of Human Papillomavirus Immunization. J of Women’s health & Gender-based medicine 2000, 9(1):47-50.
Zimet GD, Blythe MJ and Fortenberry JD: Vaccine characteristics and acceptability of HIV immunization among adolescents. Int J STD AIDS 2000, 11(3):143-149.
McPartland TS, Weaver BA, Lee SK and Koutsky LA. Men’s perceptions and knowledge of human papillomavirus (HPV) infection and cervical cancer. Journal of American College Health. 2005;53(3):225–230.
Holcomb B, Bailey JM, Crawford K and Ruffin MT. Adults’ knowledge and behaviors related to human papillomavirus infection. The Journal of the American Board of Family Practice. 2004;17(1):26–31.
Kahn JA, Rosenthal SL, Succop PA, Ho Gym and Burk RD. Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics. 2002;109(1):E5.
Dobson S, Deeks S and Money D: Déclaration sur le vaccin contre le virus du papillome humain. CCDR RMTC 2007, 33:32
Sauvageau C, Duval B, Gilca V, Lavoie F and Ouakki M. Human Papilloma Virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada .BMC Public Health 2007, 7:304
Zimet GD, Perkins SM, Sturn LM, Bair RM .Julia BE and Mays RM .Predictors of STI vaccine acceptability among parents and their adolescent children. J Adolesc Med 2005;37:179-186.